Exact Mass: 388.2460906

Exact Mass Matches: 388.2460906

Found 9 metabolites which its exact mass value is equals to given mass value 388.2460906, within given mass tolerance error 2.048E-11 dalton. Try search metabolite list with more accurate mass tolerance error 4.096E-12 dalton.

5,6-Dihydroxyprostaglandin F1a

7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-5,6-dihydroxyheptanoic acid

C20H36O7 (388.2460906)


Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. [HMDB] Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.

   

Norcaperatic acid

Norcaperatic acid

C20H36O7 (388.2460906)


   

(13R)-13-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

(13R)-13-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

C20H36O7 (388.2460906)


   

14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid

C20H36O7 (388.2460906)


   

5,6-Dihydroxyprostaglandin F1a

5,6-Dihydroxyprostaglandin F1a

C20H36O7 (388.2460906)


   

(1s,2s)-2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid

(1s,2s)-2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid

C20H36O7 (388.2460906)


   

2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid

2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid

C20H36O7 (388.2460906)


   

(1s,2r)-2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid

(1s,2r)-2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid

C20H36O7 (388.2460906)


   

(2s,3r,4r,5r)-2-{[(2e,6e)-10,11-dihydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

(2s,3r,4r,5r)-2-{[(2e,6e)-10,11-dihydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]oxy}oxane-3,4,5-triol

C20H36O7 (388.2460906)